34 min listen
Should We Be Concerned About Resistance and Development of New Variants With COVID-19 Antiviral Therapy?
Should We Be Concerned About Resistance and Development of New Variants With COVID-19 Antiviral Therapy?
ratings:
Length:
7 minutes
Released:
Jan 4, 2023
Format:
Podcast episode
Description
Fernando Carnavali, MD; Rasika Karnik, MS, MD; Renslow Sherer, MD; and Joseph Torrisi, PharmD, BCIDP, discuss COVID-19 treatments and the possibility for antiviral resistance, including:Treatment resistance mechanismsCOVID-19 testingCOVID-19 treatments, including antivirals and monoclonal antibodiesPresenters:Fernando Carnavali, MDAssociate Professor of MedicineDivision ChiefGeneral Internal MedicineDepartment of MedicineSite DirectorCOVID Center of Excellence Satellite-Ansonia Mount Sinai Health New York, New YorkRasika Karnik, MS, MDAssistant ProfessorDivision of Primary CareDepartment of Internal MedicineUniversity of ChicagoMedical DirectorPost-COVID Recovery ClinicChicago, IllinoisRenslow Sherer, MDDirectorInternational HIV Training CenterProfessor of MedicineSection of Infectious Diseases and Global HealthDepartment of MedicineUniversity of ChicagoChicago, IllinoisJoseph Torrisi, PharmD, BCIDPClinical Pharmacy SpecialistInfectious Diseases PharmacyGrady Health SystemAtlanta, GeorgiaLink to slides: https://bit.ly/3hXMgIdLink to full program: https://bit.ly/3G271KL
Released:
Jan 4, 2023
Format:
Podcast episode
Titles in the series (100)
COVID-19: Answering the Questions, Part 7: In Part 7 of this ongoing 12-part COVID-19 series, listen to a brief update on COVID-19 risk and prevention strategies among healthcare workers by Leo Yee-Sin, MBBS, MPH, MRCP, FRCP, FAMS. by CCO Infectious Disease Podcast